Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
Gestores bibliográficos
Compartir
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
Dove Press Limited
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
20
item.page.accessRights
item.page.other
item.page.references
Abstract
Since the discovery of chlorpromazine (CPZ) in 1952, first-generation antipsychotics (FGAs) have revolutionized psychiatric care in terms of facilitating discharge from hospital and enabling large num...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Ther Clin Risk Manag. 2017 Jun 29;13:757-777
Keywords
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
2 1,5 1 0,5 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026